Is a complete YDES research report available?

No complete published report is available for YD Bio Limited (YDES) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

YD Bio Limited (YDES)

NASDAQ: YDES · USD

$2.27

-0.03 (-1.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first YDES analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	159.6M
Revenue (ttm)	510.4K
Net income (ttm)	-1.4M
EPS (ttm)	-$1.29
Shares out	70.3M
Volume	14,620
Beta	-0.13

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 510.4K
Net income (ttm): -1.4M
EPS (ttm): -$1.29
Market cap: 159.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All YDES indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002011674
Company name	YD Bio Limited
Country	Taiwan
Country code	US
Cusip	G98301107
Enterprise value	$157.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	KYG983011076
Last refreshed	2026-07-30
Market cap	$159.6M
Market cap category	Micro-Cap
Price	$2.27
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	8071
Symbol	YDES
Website	https://www.ydesgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.88%
EV/Sales	309.43x
FCF yield	-1.19%
P/B ratio	0.5x
P/S ratio	315.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-883.31%
EBITDA Margin	-848.19%
Gross margin	30.44%
Gross Profit	$155,356
Gross Profit Growth	1.25%
Gross Profit Growth Q	21.98%
Net Income	$-1.4M
Net Income Growth Years	0%
Pretax Margin	-271.67%
Profit Margin	-276.58%
ROA	-25.43
ROCE	-79.86
ROE	-42.69
ROIC	-42.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-81.11%
Cagr3y	-41.54%
Cagr5y	-25.7%
EPS Growth Years	0
Revenue Growth	45.76x
Revenue Growth Q	95.64x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.14
Assets	$6.9M
Cash	$3.1M
Current Assets	$3.5M
Current Liabilities	$263,060
Debt	$22,265
Debt Equity	$0
Equity	$6.6M
Interest Coverage	-6,828.7
Liabilities	$273,980
Long Term Assets	$3.4M
Long Term Liabilities	$10,920
Net Cash	$3.1M
Net Cash By Market Cap	$1.93
Net Cash Growth	7,769.12%
Net Debt Equity	$-0.47
Tangible Book Value	$3.9M
Tangible Book Value Per Share	$2.71
WACC	3.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.18
Inventory Turnover	6.65
Net Working Capital	$89,105
Quick ratio	12.91
Working Capital	$3.2M
Working Capital Turnover	$0.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.01%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-81.09%
200-day SMA	8.23
3Y total return	-80.03%
50-day SMA	2.86
50-day SMA vs 200-day SMA	50under200
5Y total return	-77.36%
All Time High	31
All Time High Change	-92.68%
All Time High Date	2025-04-15
All Time Low	1.7
All Time Low Change	33.47%
All Time Low Date	2026-07-02
ATR	0.37
Beta	-0.13
Beta1y	1.06
Beta2y	0.34
Ch YTD	-81.39
High	2.31
High52	25
High52 Date	2025-09-12
High52ch	-90.92%
Low	2.1
Low52	1.7
Low52 Date	2026-07-02
Low52ch	33.47%
Ma50ch	-20.69%
Price vs 200-day SMA	-72.44%
RSI	44.69
RSI Monthly	28.5
RSI Weekly	31.75
Sharpe ratio	0.07x
Sortino ratio	0.15
Total Return	-4.01%
Tr YTD	-81.39
Tr1m	-3.45%
Tr1w	2.67%
Tr3m	-56.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-1.5M
Operating margin	-286.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,595,088%
Float Percent	22.18%
Net Borrowing	181,874
Shares Insiders	77.39%
Shares Institutions	0.28%
Shares Out	70,319,824
Short Float	0.16%
Short Ratio	0.07
Short Shares	0.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	325,186.35x
Bv Per Share	4.57
CAPEX	$-74,914
Ch1m	-3.45
Ch1w	2.67
Ch1y	-81.09
Ch3m	-56.37
Ch3y	-80.03
Ch5y	-77.36
Ch6m	-81.46
Change	-1.35%
Change From Open	-1.77
Close	2.3
Days Gap	0.43
Depreciation Amortization	104,735
Dollar Volume	33,172.8
Earnings Date	2026-04-30
Earnings Time	amc
EBIT	$-5.3M
EBITDA	$-5.1M
EPS	$-1.29
F Score	1
FCF	$-1.9M
FCF EV Yield	-1.21x
FCF Per Share	$-0.03
Financing CF	7,727,646
Fiscal Year End	December
Founded	2,013
Income Tax	$25,080
Investing CF	-2,900,670
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2024-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-30
Ma150	6.64
Ma150ch	-65.83%
Ma20	2.21
Ma20ch	2.62%
Net CF	3,045,200
Next Earnings Date	2026-09-30
Open	2.31
Optionable	No
Position In Range	80.48
Post Close	2.27
Postmarket Change Percent	0.93
Postmarket Price	$2.29
Ppne	88,077
Price Date	2026-07-29
Ptbv Ratio	41.18
Relative Volume	0.04x
Revenue	510,360x
Tax By Revenue	4.91x
Tr6m	-81.46%
Volume	14,620
Z Score	104.6

YD Bio Limited (YDES)

Coverage state: Market snapshot only — no published research

Generate the first YDES analysis

Price

Financial snapshot

Fair-value bridge

Latest news · YDES

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All YDES indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on YDES

Frequently asked questions